Abstract
The effect of somatostatin (0.05 and 1.5 μg/kg/hr) and of thyrotropin-releasing hormone (0.1 and 1.0 μg/kg/hr) on cholecystokinin-induced gallbladder emptying was studied in healthy volunteers by means of real-time ultrasonography. In addition, the action of increasing doses (0.05, 0.15, 0.45, and 1.35 μg/kg/hr) of somatostatin on resting gallbladder volume was also evaluated. Somatostatin, at the dose of 0.05 μg/kg/hr (shown to produce blood levels similar to those measured after a meal) significantly inhibited the gallbladder contraction in response to cholecystokinin. Kinetic analysis showed that the interaction of somatostatin and cholecystokinin is of the noncompetitive type. The higher dose of the peptide (1.5 μg/kg/hr) completely suppressed cholecystokinin-induced gallbladder contraction. In experiments carried out using somatostatin alone, a progressive increase in gallbladder volume in response to increasing doses of peptide was observed. The administration of either dose of thyrotropin-releasing hormone did not affect gallbladder emptying in any of the subjects studied. It is concluded that somatostatin is a potent inhibitor of cholecystokinin action on the gallbladder. The clear effectiveness of a very low, presumably physiological, dose indicates that somatostatin may play a physiological role in the regulation of gallbladder motor activity and provides further evidence that the peptide may act as a true hormone in man. Thyrotropin-releasing hormone does not seem to affect gallbladder motility, at least under the experimental conditions of the present study.
Similar content being viewed by others
References
Creutzfeldt W, Lankisch PG, Fölsch UR: Hemmung der sekretin und cholezystokinin-pankreozymin-induzierten saft und enzymsekretion des pankreas und der gallenblasenkontraktion beim menschen durch somatostatin. Dtsch Med Wochenschr 100:1135–1138, 1975
René E, Danzinger RG, Hofmann AF, Nakagaki M: Pharmacological effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis. Gastroenterology 84:120–129, 1983
Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger RH: Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest 62:509–518, 1978
Zyznar ES, Pietri AO, Harris V, Unger RH: Evidence for the hormonal status of somatostatin in man. Diabetes 30:883–886, 1981
Penman E, Wass JAH, Medbak S, Morgan L, Lewis JM, Besser GM, Rees LH: Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81:692–699, 1981
Schusdziarra V, Harris V, Arimura A, Unger RH: Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 104:1705–1708, 1979
Johansson C, Wisen O, Efendic S, Uvnäs-Wallensten K: Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22:126–137, 1981
Souquet JC, Rambliere R, Riou JP, Beylot M, Cohen R, Mornex R, Chayvialle JA: Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14. J Clin Endocrinol Metab 56:1076–1079, 1983
O'Shaughnessy DJ, Long RG, Adrian TE, Christofides ND, Ghatei MA, Sarson DL, Bloom SR: Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. Digestion 31:234–242, 1985
Schusdziarra V, Zyznar E, Rouiller D, Boden G, Brown JC, Arimura A, Unger RH: Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207:530–532, 1980
Morley JE, Garvin TJ, Pekary AE, Hershman JM: Thyrotropin-releasing hormone in the gastrointestinal tract. Biochem Biophys Res Commun 79:314–318, 1977
Dolva LA, Hanssen KF, Aadland E, Sand T: Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man. J Clin Endocrinol Metab 56:524–529 1983
Dolva LO, Hanssen KF, Berstad A, Frey HMM: Thyrotropin-releasing hormone inhibits the pentagastrin-stimulated gastric secretion in man. A dose response study. Clin Endocrinol 10:281–286, 1979
Gullo L, Labò G: Thyrotropin-releasing hormone inhibits pancreatic enzyme secretion in humans. Gastroenterology 80:735–739, 1981
Dolva LO, Stadaas JO: Actions of thyrotropin-releasing hormone on gastrointestinal functions in man. III. Inhibition of gastric motility in response to distension. Scand J Gastroenterol 14:419–423, 1979
Gullo L, Bolondi L, Priori P, Casanova P, Labò G: Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Digestion 29:209–213, 1984
Dowd JE, Riggs DS: A comparison of estimates of Michaelis-Menten kinetic constants from various linear transformations. J Biol Chem 240:863–869, 1965
Goldstein A: Biostatistics. An Introductory Text. New York, Macmillan Company, 1964
Tallarida RJ, Murray RB: Manual of Pharmacological Calculations with Computer Programs. New York, Springer-Verlag, 1981
Johansson C, Kollberg B, Efendic S, Uvnäs-Wallensten K: Effects of graded doses of somatostatin on gallbladder emptying and pancreatic enzyme output after oral glucose in man. Digestion 22:24–31, 1981
MacGregor IL, Deveney C, Way LW, Meyer JH: The effect of acute hyperglycemia on meal stimulated gastric, biliary, and pancreatic secretion and serum gastrin. Gastroenterology 70:197–202, 1976
Guillemin R: Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 99:1653–1654, 1976
Schusdziarra V: Somatostatin — physiological and pathophysiological aspects. Scand J Gastroenterol 18 (Suppl 82): 69–84, 1983
Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor TAM, Unger RH: Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 301:285–292, 1979
Shafer RB, Marlette JM, Morley JE: The effects of lipomul, CCK, and TRH on gallbladder emptying. Clin Nucl Med 8:66–69, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gullo, L., Bolondi, L., Scarpignato, C. et al. Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying. Digest Dis Sci 31, 1345–1350 (1986). https://doi.org/10.1007/BF01299813
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01299813